Availability and Financing of CAR-T Cell Therapies: A Cross-Country Comparative Analysis
HEALTH POLICY(2024)
Key words
Chimeric antigen receptor (CAR) T-cell therapies,Advanced Therapy Medicinal Products (ATMPs),Cancer, Pharmaceutical policy,Oncology care
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined